Track the 우정바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 우정바이오 has recorded 71 public disclosures. Market capitalisation: €37.9bn. The latest transaction was filed on 4 June 2026 (Purchase). Among the most active insiders: 수성자산운용. The full history is accessible without an account.
71
Insider Decl.
n/a
Thresholds
€12,441
19 ops.
Buy Volume
n/a
39 ops.
Sell Volume
22Σ signal
Buys €12,441n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,397 of 28,134 companies
21.5
score / 100
Value
22
Quality
21
FCF yld-2.3%
Earn yld-14%
EV/EBITDA·
ROE-15%
Gross mgn27%
Net mgn-15%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.